If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £2.15m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Update: Joint services alliance w. Jubilant Biosys

8 Mar 2011 07:00

RNS Number : 4572C
Physiomics PLC
08 March 2011
 



Physiomics plc

 

(the "Company")

 

Update: Joint services alliance with Jubilant Biosys

 

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is continuing to progress its Joint Services Alliance with Jubilant Biosys Limited ("Jublilant").

Further to the announcement of 22 September 2010, Physiomics can confirm that the experimental phase of the collaboration has been completed. The Company and Jubilant have now agreed to commence commercial discussions and sign a legally binding Alliance Agreement.

A further announcement will be made if an agreement is executed.

Physiomics can also confirm that the Company's interim statement will be released in the next few days.

 

Physiomics plc

Dr Mark Chadwick, CEO 

+44 (0)1865 784985

 

WH Ireland Limited

Katy Mitchell

+44 (0) 161 832 2174

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURLLFVFVTIDIIL
Date   Source Headline
26th Jan 20187:00 amRNSNew Major Pharmaceutical Client
25th Jan 20181:34 pmRNSHolding(s) in Company
24th Jan 20188:46 amRNSHolding(s) in Company
19th Jan 201810:20 amRNSHolding(s) in Company
17th Jan 20183:52 pmRNSHolding(s) in Company
13th Dec 20172:06 pmRNSResult of AGM
12th Dec 201710:17 amRNSDirector Dealing
6th Dec 20173:00 pmRNSIssue of Equity
30th Nov 20171:38 pmRNSShare Price Movement
28th Nov 20177:00 amRNSClinical Project Completion and Services Agreement
9th Nov 20177:00 amRNSDispatch of Annual Report and Shareholder Circular
16th Oct 20177:00 amRNSFinal Results
2nd Oct 20177:00 amRNSCompany Update
31st Jul 20177:00 amRNSTwo New Pre-Clinical Contracts
6th Jun 20177:00 amRNSPhysiomics to Attend PAGE 2017
24th May 20177:00 amRNSUpdate: Two Further Extension Projects
5th May 20177:00 amRNSPhysiomics to Present at BioTrinity 2017
24th Mar 201711:15 amRNSInterim Results Statement
11th Jan 20177:00 amRNSCompany Update
6th Jan 20177:00 amRNSConfirmation of Award of Innovate UK Grant
22nd Dec 20163:31 pmRNSDirector Dealing
22nd Dec 20167:00 amRNSIssue of Options
16th Dec 20161:00 pmRNSResult of AGM
5th Dec 20167:00 amRNSPayment for in-silico modelling of inhibitor
23rd Nov 20167:00 amRNSPosting of Financial Results and Notice of AGM
22nd Nov 20167:00 amRNSProvisional Award of Innovate UK Grant
27th Oct 20163:00 pmRNSFinal Results for the year ended 30 June 2016
26th Oct 20167:00 amRNSPresentation at Conference on Pharmacometrics
25th Oct 20167:00 amRNSDirectorate Change
28th Sep 20167:00 amRNSAdvisor Changes
21st Sep 20167:00 amRNSPlacing and Update on Acquisition
7th Sep 201612:19 pmRNSResult of GM
22nd Aug 20167:00 amRNSNotice of General Meeting
18th Aug 20167:00 amRNSSigning of Share Purchase Agreement with BioMoti
16th Aug 20161:05 pmRNSAdvisor Changes
16th May 20167:00 amRNSExtensions for Virtual Tumour Project
3rd May 20167:00 amRNSAppointment of part-time Head of Finance
18th Apr 20169:02 amRNSPhysiomics Appoints New Chief Executive Officer
6th Apr 201610:15 amRNSVirtual Tumour Developments Presentation at AACR
4th Apr 201612:12 pmRNSNew Speciality Pharma Customer for new Indication
31st Mar 20167:01 amRNSInterim Results Statement
31st Mar 20167:00 amRNSHeads of Terms with BioMoti and Board Changes
22nd Dec 201512:08 pmRNSIssue of Options
22nd Dec 20157:00 amRNSNew Speciality Pharma Customer for New Indication
18th Dec 201510:57 amRNSPlacing
14th Dec 201510:29 amRNSResult of General Meeting
4th Dec 201511:38 amRNSResult of AGM
27th Nov 20154:15 pmRNSNotice of General Meeting
10th Nov 20157:00 amRNSFinal Results
6th Nov 20157:00 amRNSStrategic Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.